TY - JOUR T1 - Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. SP - 210 LP - 212 DO - 10.2967/jnmt.119.226019 VL - 47 IS - 3 AU - Harvey A. Ziessman Y1 - 2019/09/01 UR - http://tech.snmjournals.org/content/47/3/210.abstract N2 - Sincalide (Kinevac) is widely used in conjunction with cholescintigraphy for a variety of clinical indications. Over the years, numerous publications have verified the optimal infusion methodology. Published data and consensus recommendations emphasize that sincalide, 0.02 μg/kg, should be infused over 60 min. Production problems sometimes limit the availability of sincalide. In that case, non–Food and Drug Administration pharmacy-compounded sincalide may serve as an alternative. Fatty meals have also been used. Various illnesses and drugs may inhibit gallbladder contraction. Thus, these drugs should be withheld for 48 h before the study. Sincalide cholescintigraphy is most commonly used to diagnose or exclude chronic acalculous gallbladder disease. The study should preferably be performed as an outpatient procedure. ER -